⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAFW News
bioAffinity Technologies, Inc. Warrant
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
prnewswire.com
BIAFW
BIAF
bioAffinity Technologies Announces Closing of $3.2 Million Offering
businesswire.com
BIAFW
BIAF
WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering
prnewswire.com
BIAFW
BIAF
bioAffinity Technologies Announces Pricing of $3.2 Million Offering
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar
businesswire.com
BIAFW
BIAF